CGC.US Canopy Growth Corp

Healthcare Pharmaceuticals USA Stocks
0.5960 USD
Close of Nov 13, 2026
0.5432 2.38
Market cap
USD 252M
P/E
-
P/B
0.53x
ROE
-17.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is CGC.US undervalued?

Graham number

The Graham number of Canopy Growth Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Canopy Growth Corp fundamental analysis

No fundamental analysis for Canopy Growth Corp yet.

Canopy Growth Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Canopy Growth Corp

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and ca…

Full company profile